For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Cobitolimod | 2 doses 4 weeks apart Cobitolimod: 30 mg rectal dose at week 0 and 4 | None | None | 10 | 87 | 31 | 87 | View |
| Placebo | 2 doses 4 weeks apart Placebo: Rectal dose at week 0 and 4 | None | None | 8 | 43 | 6 | 43 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Anemia | NON_SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | MedDra 14.1 | View |
| Perirectal abscess | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | MedDra 14.1 | View |
| Herpes Zoster | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDra 14.1 | View |
| Clostridial infection | NON_SYSTEMATIC_ASSESSMENT | Reproductive system and breast disorders | MedDra 14.1 | View |
| Vomiting | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | MedDra 14.1 | View |
| Overdose | NON_SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | MedDra 14.1 | View |
| Osteoarthritis | NON_SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | MedDra 14.1 | View |
| Spinal compression fracture | NON_SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | MedDra 14.1 | View |
| Sensory Distrurbance | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | MedDra 14.1 | View |
| Movement disorder | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | MedDra 14.1 | View |
| Benign Dysplaisa | NON_SYSTEMATIC_ASSESSMENT | Reproductive system and breast disorders | MedDra 14.1 | View |
| Pneumonia | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | MedDra 14.1 | View |
| Rash | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | MedDra 14.1 | View |
| Epistaxis | NON_SYSTEMATIC_ASSESSMENT | Vascular disorders | MedDra 14.1 | View |
| Acute Coronary syndrome | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | MedDra 14.1 | View |
| Myocardial Ischemia | NON_SYSTEMATIC_ASSESSMENT | Cardiac disorders | MedDra 14.1 | View |
| Glaucoma | NON_SYSTEMATIC_ASSESSMENT | Eye disorders | MedDra 14.1 | View |
| Retinal Veon Thrombosis | NON_SYSTEMATIC_ASSESSMENT | Eye disorders | MedDra 14.1 | View |
| Intestinal obstruction | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | MedDra 14.1 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Anemia | NON_SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | MedDra 14.1 | View |
| Cushingoid | NON_SYSTEMATIC_ASSESSMENT | Endocrine disorders | MedDra 14.1 | View |
| Abdominal Pain | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | MedDra 14.1 | View |
| Nasopharyngitis | NON_SYSTEMATIC_ASSESSMENT | Infections and infestations | MedDra 14.1 | View |
| Back Pain | NON_SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | MedDra 14.1 | View |
| Headache | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | MedDra 14.1 | View |
| Depression | NON_SYSTEMATIC_ASSESSMENT | Psychiatric disorders | MedDra 14.1 | View |
| Rash | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | MedDra 14.1 | View |